Bu Fei e Jiao Tang (Tonify the Lungs Decoction with Ass Hide Gelatin)

Actions

Indications

Western Uses:

• What is Bu Fei E Jiao Tang used for in modern practice?

  In modern practice Bu Fei E Jiao Tang is referenced for chronic, “dry-type” respiratory conditions — states Western medicine would frame as chronic dry cough, chronic bronchitis, bronchiectasis, or a dry cough with blood-tinged sputum — where the traditional heat-in-deficiency pattern is present.

  This biomedical correlate is offered as a reference to the formula’s traditional use, not as a claim that it treats any diagnosed disease. A significant modern-practice caveat: Ma Dou Ling, one of its deputy herbs, contains aristolochic acid, and products containing Aristolochia species have been restricted since a 2001 US FDA import alert and by regulators in many other countries. As a result, contemporary practitioners generally do not compound this formula as classically written — they omit or substitute Ma Dou Ling (see notes). Any use for a diagnosed condition belongs with a qualified practitioner and appropriate medical care.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies; Ma Dou Ling regulatory status from the US FDA aristolochic-acid import alert (2001). Reference only, not a treatment claim.

Originally Appeared In:

• Craft of Medicinal Treatment for Childhood Disease Patterns (Xiao Er Yao Zheng Zhi Jue)

Notes:

• How does Bu Fei E Jiao Tang compare to other Lung-yin formulas, and how is it modified?

  Bu Fei E Jiao Tang is chosen over related Lung-yin formulas specifically when blood-streaked sputum and clear heat signs predominate in a chronic dry cough.

  • vs Bai He Gu Jin Tang: a larger formula that nourishes both Lung and Kidney yin together — better suited to deeper or longer-standing yin depletion than Bu Fei E Jiao Tang addresses alone.
  • vs Mai Men Dong Tang: that formula centers on Stomach yin failing to nourish the Lung (rebellious qi, Ban Xia to descend it); Bu Fei E Jiao Tang is preferred when Lung-heat and bleeding signs are more prominent than digestive rebellion.
  • vs Bu Fei Tang: a contrasting approach — Bu Fei Tang tonifies Lung qi (Ren Shen, Huang Qi) for a weak cough with spontaneous sweating and a pale tongue, not the yin-deficiency-with-heat pattern here.

  Common modifications: add Bai Ji and Xian He Cao to strengthen the hemostatic effect when blood-streaked sputum is pronounced; add Tian Men Dong and Bei Sha Shen for more severe dryness with scanty phlegm; substitute Sang Bai Pi for Ma Dou Ling to retain Lung heat-clearing action while avoiding aristolochic acid exposure.

  Source: Bensky & Barolet, Formulas & Strategies (formula comparisons and modifications), cross-referenced against multiple online sources.

Clinical Studies & Research:

• Is there modern research on Bu Fei E Jiao Tang?

  Yes, but modern research on this formula centers on the safety of Ma Dou Ling rather than on the formula’s tonifying efficacy. A mouse metabolomics and histopathology study tested the compound formula (referred to as Bu-Fei-A-Jiao-Tang, BFAJT) alongside pure aristolochic acid and Ma Dou Ling alone, to see whether the classical chief-deputy-assistant-envoy design could reduce Ma Dou Ling’s kidney toxicity. It found all three — the AA standard, Ma Dou Ling alone, and the full BFAJT formula — were nephrotoxic in this model, with damage concentrated in the proximal tubules; combining Ma Dou Ling with the formula’s other herbs did not measurably offset the toxicity.

  • Formula-specific nephrotoxicity (mouse, preclinical): metabolomic and histopathological analysis found Bu-Fei-A-Jiao-Tang nephrotoxic despite its classical formula design (PMID 23606874; PMC 3626396).
  • Broader context (review): aristolochic acid nephropathy is a well-documented, dose-related risk associated with Aristolochia-containing herbs generally, including a distinctive mutational signature and elevated urinary-tract cancer risk (PMID 23238808).

  Sources: PubMed 23606874 / PMC 3626396; PubMed 23238808. Research context on ingredient safety, not a claim of therapeutic effect; no clinical-efficacy trials of the compound formula were found.